Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amphetamine | 3 | 2010 | 103 | 0.730 |
Why?
|
| Central Nervous System Stimulants | 4 | 2010 | 219 | 0.700 |
Why?
|
| Dextroamphetamine | 5 | 2010 | 108 | 0.610 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2011 | 2415 | 0.570 |
Why?
|
| Emotions | 4 | 2014 | 354 | 0.490 |
Why?
|
| Reflex, Startle | 4 | 2014 | 32 | 0.410 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 2 | 2009 | 6 | 0.410 |
Why?
|
| Ethanolamines | 1 | 2012 | 24 | 0.410 |
Why?
|
| Stress, Psychological | 2 | 2012 | 322 | 0.390 |
Why?
|
| Arousal | 3 | 2014 | 170 | 0.360 |
Why?
|
| Euphoria | 1 | 2010 | 43 | 0.360 |
Why?
|
| Receptors, Opioid, mu | 1 | 2010 | 45 | 0.360 |
Why?
|
| Amidohydrolases | 1 | 2009 | 18 | 0.340 |
Why?
|
| Personality | 2 | 2020 | 136 | 0.340 |
Why?
|
| Monoamine Oxidase | 1 | 2009 | 25 | 0.330 |
Why?
|
| Fatigue | 1 | 2009 | 174 | 0.310 |
Why?
|
| Genetic Variation | 3 | 2010 | 1380 | 0.280 |
Why?
|
| Cross-Over Studies | 4 | 2010 | 387 | 0.260 |
Why?
|
| Genotype | 10 | 2014 | 1852 | 0.260 |
Why?
|
| Young Adult | 10 | 2012 | 6418 | 0.230 |
Why?
|
| Haplotypes | 4 | 2010 | 637 | 0.230 |
Why?
|
| Adolescent | 10 | 2012 | 9347 | 0.220 |
Why?
|
| Double-Blind Method | 7 | 2014 | 1714 | 0.210 |
Why?
|
| Catechol O-Methyltransferase | 3 | 2014 | 69 | 0.210 |
Why?
|
| Caffeine | 3 | 2012 | 83 | 0.210 |
Why?
|
| Cold Temperature | 1 | 2022 | 160 | 0.190 |
Why?
|
| Polymorphism, Genetic | 4 | 2014 | 824 | 0.190 |
Why?
|
| Mitochondrial Dynamics | 1 | 2022 | 56 | 0.190 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2020 | 8 | 0.180 |
Why?
|
| Alleles | 3 | 2014 | 1137 | 0.180 |
Why?
|
| Adult | 15 | 2020 | 26836 | 0.180 |
Why?
|
| Aorta | 1 | 2022 | 289 | 0.180 |
Why?
|
| Endocannabinoids | 1 | 2020 | 31 | 0.170 |
Why?
|
| Heart Rate | 2 | 2012 | 498 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2022 | 464 | 0.160 |
Why?
|
| Mitochondria | 1 | 2022 | 556 | 0.150 |
Why?
|
| Male | 15 | 2016 | 42705 | 0.140 |
Why?
|
| Chemokine CCL17 | 1 | 2016 | 3 | 0.140 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2016 | 3 | 0.140 |
Why?
|
| Plasmodium berghei | 1 | 2016 | 2 | 0.140 |
Why?
|
| Malaria, Cerebral | 1 | 2016 | 4 | 0.140 |
Why?
|
| Affect | 4 | 2012 | 389 | 0.130 |
Why?
|
| Female | 15 | 2016 | 46617 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 75 | 0.130 |
Why?
|
| Anxiety | 3 | 2014 | 311 | 0.120 |
Why?
|
| Receptor, Adenosine A2A | 2 | 2012 | 16 | 0.120 |
Why?
|
| Dopamine | 1 | 2014 | 276 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2012 | 899 | 0.110 |
Why?
|
| Surveys and Questionnaires | 2 | 2012 | 2658 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 494 | 0.100 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2012 | 13 | 0.100 |
Why?
|
| Receptors, Neuropeptide | 1 | 2012 | 8 | 0.100 |
Why?
|
| Neuropeptides | 1 | 2012 | 115 | 0.100 |
Why?
|
| Humans | 15 | 2020 | 90014 | 0.090 |
Why?
|
| Stimulation, Chemical | 1 | 2010 | 63 | 0.090 |
Why?
|
| Gene Frequency | 2 | 2009 | 687 | 0.090 |
Why?
|
| Lipids | 1 | 2012 | 275 | 0.090 |
Why?
|
| Linkage Disequilibrium | 2 | 2009 | 477 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 2012 | 301 | 0.090 |
Why?
|
| Chromosomes | 1 | 2010 | 98 | 0.090 |
Why?
|
| Acute Disease | 1 | 2012 | 846 | 0.090 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2010 | 36 | 0.090 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2010 | 36 | 0.080 |
Why?
|
| Menstrual Cycle | 1 | 2010 | 54 | 0.080 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2009 | 57 | 0.080 |
Why?
|
| Hormones | 1 | 2010 | 139 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 338 | 0.080 |
Why?
|
| Wakefulness | 1 | 2009 | 135 | 0.080 |
Why?
|
| Time Factors | 2 | 2022 | 5361 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2009 | 295 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 1731 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2010 | 906 | 0.070 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 421 | 0.070 |
Why?
|
| Impulsive Behavior | 1 | 2009 | 289 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 869 | 0.060 |
Why?
|
| Attention | 1 | 2010 | 396 | 0.060 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2022 | 29 | 0.050 |
Why?
|
| GTP Phosphohydrolases | 1 | 2022 | 74 | 0.050 |
Why?
|
| Dynamins | 1 | 2022 | 50 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 316 | 0.050 |
Why?
|
| Arachidonic Acids | 1 | 2020 | 41 | 0.040 |
Why?
|
| Swine | 1 | 2022 | 590 | 0.040 |
Why?
|
| Feedback | 1 | 2020 | 134 | 0.040 |
Why?
|
| Cell Survival | 1 | 2022 | 983 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2022 | 1130 | 0.040 |
Why?
|
| Reward | 1 | 2020 | 193 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2010 | 506 | 0.040 |
Why?
|
| Mannose-Binding Lectins | 1 | 2016 | 6 | 0.030 |
Why?
|
| Arginase | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2022 | 2887 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2016 | 86 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 155 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 200 | 0.030 |
Why?
|
| Carbidopa | 1 | 2014 | 5 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 1778 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 288 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 311 | 0.030 |
Why?
|
| Levodopa | 1 | 2014 | 37 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 203 | 0.030 |
Why?
|
| Macrophages | 1 | 2016 | 582 | 0.030 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2012 | 3 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2016 | 0.020 |
Why?
|
| Brain | 1 | 2020 | 2306 | 0.020 |
Why?
|
| Luteal Phase | 1 | 2010 | 14 | 0.020 |
Why?
|
| Animals | 2 | 2022 | 27536 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2009 | 48 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 211 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 338 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2009 | 109 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2395 | 0.020 |
Why?
|
| Reaction Time | 1 | 2009 | 311 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1075 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 186 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2010 | 328 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2007 | 91 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2009 | 497 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 437 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1929 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 885 | 0.010 |
Why?
|
| Depression | 1 | 2007 | 512 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 2360 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 11858 | 0.010 |
Why?
|
| DNA | 1 | 2007 | 1311 | 0.010 |
Why?
|